{
    "Trade/Device Name(s)": [
        "Seradyn QMS\u00ae Topiramate"
    ],
    "Submitter Information": "Seradyn, Inc",
    "510(k) Number": "K070645",
    "Predicate Device Reference 510(k) Number(s)": [
        "K970510"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NWM"
    ],
    "Summary Letter Date": "March 05, 2007",
    "Summary Letter Received Date": "March 08, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3660"
    ],
    "Regulation Name(s)": [
        "Phenobarbital test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Topiramate"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous particle-enhanced turbidimetric immunoassay",
        "Particle agglutination (PETIA)"
    ],
    "Methodologies": [
        "Turbidimetric immunoassay",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Seradyn QMS Topiramate assay for quantitative measurement of topiramate in serum or plasma using automated clinical chemistry analyzers",
    "Indications for Use Summary": "Quantitative determination of topiramate in human serum or plasma on automated clinical chemistry analyzers to aid in diagnosis and treatment of topiramate overdose and in monitoring therapy",
    "fda_folder": "Toxicology"
}